# Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19

> **NCT04597034** · NA · UNKNOWN · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 35 (estimated)

## Conditions studied

- Covid19
- AKI

## Interventions

- **PROCEDURE:** AN69-Oxiris
- **PROCEDURE:** AN69-Standard

## Key facts

- **NCT ID:** NCT04597034
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-02
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04597034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04597034, "Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04597034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*